Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc

<< Previous

Bullboard Posts

Next >>

Post by scarlet1967on Jun 25, 2021 9:11am

136 Views

Post# 33449659

Akero’s YouTube clip on NASH

They put a clip on websedgemedicin platform, Stephen Harrison must be on their payroll.
That platform has over 11k subscribers and averaging about 1000 views per clip.
Not the best platform but far better than THTX's some 30 views.
Point is even a more recognized NASH company is using third party social media platforms to get exposure.

https://youtu.be/0jrSTKd02ZI

<< Previous

Bullboard Posts

Next >>

Telesat secures $2.54B government funding for Lightspeed satellites